cyclosporine has been researched along with Movement Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixit, A; Gupta, M; Madkaikar, M; Patil, V | 1 |
| Borlongan, CV; Hess, DC; Yu, G | 1 |
| Asanuma, M; Kondo, Y; Ogawa, N | 1 |
1 review(s) available for cyclosporine and Movement Disorders
| Article | Year |
|---|---|
[Involvement of immune mechanism in the progressive brain damage].
Topics: Animals; Brain Damage, Chronic; Cyclosporine; Cytokines; Epilepsy; Humans; Movement Disorders; Nerve Degeneration; Neuroglia; Receptors, Muscarinic | 1994 |
2 other study(ies) available for cyclosporine and Movement Disorders
| Article | Year |
|---|---|
Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W).
Topics: Adult; Brain Stem; Child, Preschool; Codon; Cyclosporine; Demyelinating Diseases; Dexamethasone; Exons; Female; Ferritins; Frontal Lobe; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Muscle Weakness; Mutation, Missense; Perforin; Recurrence; Respiratory Tract Infections | 2017 |
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome | 2004 |